Sanofi (SNY)
44.46
+0.09
(+0.20%)
USD |
NASDAQ |
Sep 02, 16:00
44.46
0.00 (0.00%)
After-Hours: 17:13
Sanofi Cash from Operations (Annual) : 12.13B for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 12.13B |
| December 31, 2024 | 9.823B |
| December 31, 2023 | 11.09B |
| December 31, 2022 | 11.06B |
| December 31, 2021 | 12.44B |
| December 31, 2020 | 8.456B |
| December 31, 2019 | 8.667B |
| December 31, 2018 | 6.544B |
| December 31, 2017 | 8.323B |
| December 31, 2016 | 9.053B |
| December 31, 2015 | 9.892B |
| December 31, 2014 | 10.20B |
| December 31, 2013 | 9.232B |
| December 31, 2012 | 10.50B |
| Date | Value |
|---|---|
| December 31, 2011 | 12.96B |
| December 31, 2010 | 13.05B |
| December 31, 2009 | 11.84B |
| December 31, 2008 | 12.47B |
| December 31, 2007 | 9.727B |
| December 31, 2006 | 8.289B |
| December 31, 2005 | 7.930B |
| December 31, 2004 | 5.052B |
| December 31, 2003 | 2.560B |
| December 31, 2002 | 1.580B |
| December 31, 2001 | 1.626B |
| December 31, 2000 | 1.104B |
| December 31, 1999 | 881.10M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| AstraZeneca PLC | 14.90B |
| GSK Plc | 9.625B |
| Johnson & Johnson | 24.53B |
| Eli Lilly & Co. | 16.81B |
| Merck & Co., Inc. | 16.47B |